Last reviewed · How we verify

NCT03717779

Contribution LUS in the Diagnosis of Acute Heart Failure (AHF) in Patients Admitted to the ED

Completed Last updated 16 January 2019
What this trial tests

trial testing lung ultrasound in Dyspnea; Cardiac in 600 participants. Completed in 1 October 2017.

Timeline
2 January 2016
Primary endpoint
1 October 2017
1 October 2017

Quick facts

Lead sponsorUniversity of Monastir
StatusCompleted
Study typeOBSERVATIONAL
Enrollment600
Start date2 January 2016
Primary completion1 October 2017
Estimated completion1 October 2017
Sites1 location across Tunisia

Drugs / interventions tested

Conditions studied

Sponsor

University of Monastir

Who can join

Adults 18 to 90, any sex, with Dyspnea; Cardiac. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study assesses the potential of lung ultrasonography to diagnose heart failure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Bedside lung ultrasonography by emergency department residents as an aid for identifying heart failure in patients with acute dyspnea after a 2-h training course.
    Msolli MA, Sekma A, Marzouk MB, Chaabane W, et al · · 2021 · cited 7× · PMID 33559777 · DOI 10.1186/s13089-021-00207-9

Verify or expand the search:

Other trials of lung ultrasound

Trials testing the same drug.

Other recruiting trials for Dyspnea; Cardiac

Currently open trials in the same condition.

Other University of Monastir trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03717779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing